IL13Ralpha2-Targeted Chimeric Antigen Receptor (CAR) T Cells with or Without Nivolumab and Ipilimumab in Treating Patients with Recurrent or Refractory Glioblastoma(NCT 04003649). This evidence concerns the gene IL13RA2 and glioblastoma.